HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

House Passes the Lymphedema Treatment Act

November 17, 2022 by David Kopf

In a 402-13 bipartisan vote, the House of Representatives passed the Lymphedema Treatment Act, which would require Medicare to fund compression garments for the treatment of beneficiaries’ lymphedema.

Rep. Earl L. "Buddy" Carter (R-Ga.) and Rep. Jan Schakowsky (D-Ill.) introduced the Act, H.R. 3630, into the House to ensure Medicare Part B coverage of doctor-prescribed compression garments. The bill was also co-led by Reps. Earl Blumenauer (D-Ore.) and Mike Kelly (R-Penn.).

"We are one step closer to providing relief for lymphedema patients, some of whom live through one of the worst diagnoses imaginable – cancer – only to come out the other side with an equally debilitating condition and a fraction of the resources and support," Rep. Carter said. "As co-chair of the Cancer Survivors Caucus and a pharmacist, I am excited to see Congress provide relief to patients who have been denied Medicare coverage for far too long."

"Today, the House of Representatives took one giant step closer to finally providing needed relief to over three million Lymphedema patients on Medicare," Rep. Schakowsky added. "The bill passed the House with overwhelming bipartisan support thanks to the tireless work of advocates like Heather Ferguson, Founder and Executive Director of the Lymphedema Advocacy Group, and her teenage sons."

Schakowsky says the legislation has "tremendous bipartisan support" in the Senate.

"We can get this bill to President Biden’s desk before the end of the year," she said. "Millions of Lymphedema patients are counting on us."

 

Related Articles Read More >

Wound Care Association Urges Public Comments on CY 2027 Medicare Physician Fee Schedule
Comments are due by Sept. 14.
New Study Examines Medicare Advantage Prior Authorization Denials, Successful Appeals
KFF analysis showed appeals are often successful, but not often used.
LUX Infusion Acquires Infuse IQ
Florida-based LUX Infusion provides home infusion and ambulatory infusion services.
September Wellness Challenge to Benefit NHIF Research Grant Program
The National Home Infusion Foundation is encouraging industry professionals to care for themselves and others.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe